Last Price
284.49
Today's Change
+1.03 (0.36%)
Day's Change
276.63 - 289.91
Trading Volume
165,091
Market Cap
6 Billion
Shares Outstanding
21 Million
Avg Volume
439,329
Avg Price (50 Days)
262.19
Avg Price (200 Days)
223.79
PE Ratio
-12.29
EPS
-23.14
Earnings Announcement
07-Aug-2024
Previous Close
283.46
Open
287.67
Day's Range
276.63 - 289.9115
Year Range
119.76 - 299.98
Trading Volume
165,091
1 Day Change
0.36%
5 Day Change
1.12%
1 Month Change
3.32%
3 Month Change
47.15%
6 Month Change
25.90%
Ytd Change
25.40%
1 Year Change
41.30%
3 Year Change
233.05%
5 Year Change
237.07%
10 Year Change
102.20%
Max Change
-10.58%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.